Insider · CIK 0001727275

Fairey William

Reports to the SEC for 7 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001727275

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Deferred Stock UnitsA Award	Director	AAward	+1,980 sh	—	—	1,980
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,772 sh	—	—	3,772
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-10-01	KalVista Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-07-23	RNTXRein Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2025-06-11	MIRMMirum Pharmaceuticals, Inc.S Sale	Director	SSale	−3,203 sh	$48.42	−$155K	2,500
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Deferred Stock UnitsA Award	Director	AAward	+3,977 sh	—	—	3,977
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,268 sh	—	—	6,268
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,703 sh	—	—	0
2025-05-29	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,703 sh	—	—	5,703
2024-12-02	RNTXRein Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2024-10-03	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-08-20	RNTXRein Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,725 sh	—	—	2,725
2024-06-05	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+5,703 sh	—	—	5,703
2024-06-05	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,779 sh	—	—	8,779
2024-04-18	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2023-10-31	RNTXRein Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,450 sh	—	—	5,450
2023-06-12	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17K sh	—	—	17,000
2022-06-02	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.8K sh	—	—	12,750
2021-08-19	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+34K sh	—	—	34,000
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	EVP, Chief Commercial Officer	DDisposition to Issuer	−39K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	EVP, Chief Commercial Officer	DDisposition to Issuer	−69.5K sh	—	—	0
2020-11-17	MyoKardia, Inc.U Disposition from Tender	EVP, Chief Commercial Officer	UDisposition from Tender	−42.2K sh	—	—	0
2020-02-14	MyoKardia, Inc.Stock Option (Right to Buy)A Award	EVP, Chief Commercial Officer	AAward	+39K sh	—	—	39,022
2020-02-14	MyoKardia, Inc.Restricted Stock UnitsA Award	EVP, Chief Commercial Officer	AAward	+12.6K sh	—	—	12,598
2020-02-01	MyoKardia, Inc.S Sale	EVP, Chief Commercial Officer	SSale	−2,899 sh	$68.04	−$197K	5,226
2020-02-01	MyoKardia, Inc.M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+8,125 sh	—	—	8,125
2020-02-01	MyoKardia, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−8,125 sh	—	—	24,375
2019-02-01	MyoKardia, Inc.Stock Option (Right to Buy)A Award	EVP, Chief Commercial Officer	AAward	+69.5K sh	—	—	69,500
2019-02-01	MyoKardia, Inc.Restricted Stock UnitsA Award	EVP, Chief Commercial Officer	AAward	+32.5K sh	—	—	32,500
2018-01-03	ChemoCentryx, Inc.Stock Option (right to buyA Award	Chief Operating Officer	AAward	+575K sh	—	—	575,000

Recent filings

Accepted (ET)
Jun 174
Fairey William0001727275-26-000004
SEC(opens sec.gov)
Jun 114
Fairey William0001727275-26-000002
SEC(opens sec.gov)
Oct 24
Fairey William0001727275-25-000003
SEC(opens sec.gov)
Jul 234
Fairey William0000950170-25-098041
SEC(opens sec.gov)
Jun 134
Fairey William0001415889-25-017188
SEC(opens sec.gov)
Jun 24
Fairey William0001415889-25-015302
SEC(opens sec.gov)
Dec 64
Fairey William0000950170-24-134153
SEC(opens sec.gov)
Oct 44
Fairey William0001415889-24-024753
SEC(opens sec.gov)
Aug 224
Fairey William0000950170-24-099837
SEC(opens sec.gov)
Jun 74
Fairey William0001415889-24-016063
SEC(opens sec.gov)
Apr 224
Fairey William0001415889-24-011319
SEC(opens sec.gov)
Nov 24
Fairey William0000899243-23-020117
SEC(opens sec.gov)
Jun 144
Fairey William0001209191-23-037129
SEC(opens sec.gov)

Companies

Address

1001 PAGE MILL ROAD BUILDING 4, SUITE 200B

PALO ALTO, CA, 93404